299 related articles for article (PubMed ID: 30665480)
41. The impact of nail psoriasis on disease activity, quality of life, and clinical variables in patients with psoriatic arthritis: A cross-sectional multicenter study.
Cengiz G; Nas K; Keskin Y; Kılıç E; Sargin B; Acer Kasman S; Alkan H; Sahin N; Cüzdan Balta N; Gezer İA; Keskin D; Mülkoğlu C; Reşorlu H; Ataman Ş; Bal A; Baykul M; Duruöz MT; Küçükakkaş O; Yurdakul OV; Alkan Melikoğlu M; Ayhan FF; Bodur H; Çaliş M; Çapkin E; Devrimsel G; Gök K; Hizmetli S; Kamanlı A; Ecesoy H; Kutluk Ö; Şen N; Şendur ÖF; Tekeoğlu İ; Toprak M; Tolu S; Tuncer T
Int J Rheum Dis; 2023 Jan; 26(1):43-50. PubMed ID: 36165674
[TBL] [Abstract][Full Text] [Related]
42. The effect of different pulse durations in the treatment of nail psoriasis with 595-nm pulsed dye laser: a randomized, double-blind, intrapatient left-to-right study.
Treewittayapoom C; Singvahanont P; Chanprapaph K; Haneke E
J Am Acad Dermatol; 2012 May; 66(5):807-12. PubMed ID: 22243768
[TBL] [Abstract][Full Text] [Related]
43. Psoriasis patients with nail disease have a greater magnitude of underlying systemic subclinical enthesopathy than those with normal nails.
Ash ZR; Tinazzi I; Gallego CC; Kwok C; Wilson C; Goodfield M; Gisondi P; Tan AL; Marzo-Ortega H; Emery P; Wakefield RJ; McGonagle DG; Aydin SZ
Ann Rheum Dis; 2012 Apr; 71(4):553-6. PubMed ID: 22156725
[TBL] [Abstract][Full Text] [Related]
44. Incidence, clinical manifestations and clipping of nail psoriasis in the dermatology center of the Hospital Universitário Evangélico de Curitiba.
Garbers LE; Slongo H; Fabricio LH; Schmitt JV; Bonalumi A
An Bras Dermatol; 2016; 91(3):300-5. PubMed ID: 27438196
[TBL] [Abstract][Full Text] [Related]
45. Efficacy of Adalimumab for Nail Psoriasis During 24 Months of Continuous Therapy.
Kokolakis G; Bachmann F; Wolk K; Sabat R; Philipp S
Acta Derm Venereol; 2020 Jul; 100(14):adv00214. PubMed ID: 32511739
[TBL] [Abstract][Full Text] [Related]
46. [Assessment of psoriatic nail lesions therapy by means of nail psoriasis severity index].
Tsiskarishvili NV; Katsitadze AG; Tsiskarishvili NI
Georgian Med News; 2011 Oct; (199):43-7. PubMed ID: 22155805
[TBL] [Abstract][Full Text] [Related]
47. Improvement of scalp and nail lesions with ixekizumab in a phase 2 trial in patients with chronic plaque psoriasis.
Langley RG; Rich P; Menter A; Krueger G; Goldblum O; Dutronc Y; Zhu B; Wei H; Cameron GS; Heffernan MP
J Eur Acad Dermatol Venereol; 2015 Sep; 29(9):1763-70. PubMed ID: 25693783
[TBL] [Abstract][Full Text] [Related]
48. Treatments for nail psoriasis: a systematic review by the GRAPPA Nail Psoriasis Work Group.
Armstrong AW; Tuong W; Love TJ; Carneiro S; Grynszpan R; Lee SS; Kavanaugh A
J Rheumatol; 2014 Nov; 41(11):2306-14. PubMed ID: 25362716
[TBL] [Abstract][Full Text] [Related]
49. Psoriatic nails: a prospective clinical study.
Salomon J; Szepietowski JC; Proniewicz A
J Cutan Med Surg; 2003; 7(4):317-21. PubMed ID: 12879333
[TBL] [Abstract][Full Text] [Related]
50. Clinical characteristics of patients with facial psoriasis in Malaysia.
Syed Nong Chek SR; Robinson S; Mohd Affandi A; Baharum N
Int J Dermatol; 2016 Oct; 55(10):1092-5. PubMed ID: 27061170
[TBL] [Abstract][Full Text] [Related]
51. Evaluation of the efficacy and safety of infliximab on psoriatic nails: an unblinded, nonrandomized, open-label study.
Rigopoulos D; Gregoriou S; Stratigos A; Larios G; Korfitis C; Papaioannou D; Antoniou C; Ioannides D
Br J Dermatol; 2008 Aug; 159(2):453-6. PubMed ID: 18565184
[TBL] [Abstract][Full Text] [Related]
52. Challenge of Nail Psoriasis: An Update Review.
Ji C; Wang H; Bao C; Zhang L; Ruan S; Zhang J; Gong T; Cheng B
Clin Rev Allergy Immunol; 2021 Dec; 61(3):377-402. PubMed ID: 34478047
[TBL] [Abstract][Full Text] [Related]
53. [Psoriatic arthritis in France, from infants to the elderly: Findings from two cross-sectional, multicenter studies].
Galezowski A; Maccari F; Hadj-Rabia S; Sigal ML; Phan A; Lahfa M; Bursztejn AC; Barthélémy H; Boralévi F; Reguiai Z; Chiavérini C; Estève E; Bourrat E; Ruer-Mulard M; Beauchet A; Mahé E;
Ann Dermatol Venereol; 2018 Jan; 145(1):13-20. PubMed ID: 29146007
[TBL] [Abstract][Full Text] [Related]
54. Bioelectrical phase angle and psoriasis: a novel association with psoriasis severity, quality of life and metabolic syndrome.
Barrea L; Macchia PE; Di Somma C; Napolitano M; Balato A; Falco A; Savanelli MC; Balato N; Colao A; Savastano S
J Transl Med; 2016 May; 14(1):130. PubMed ID: 27165166
[TBL] [Abstract][Full Text] [Related]
55. Patterns of clinical nail appearances in patients with cutaneous psoriasis.
Marina EM; Botar-Jid C; Bolboaca SD; Roman II; Senila CS; Mihu CM; Tataru DA
Clujul Med; 2017; 90(1):22-27. PubMed ID: 28246493
[TBL] [Abstract][Full Text] [Related]
56. Could Psoriatic Arthritis Be Easily Diagnosed from Current Suspicious Physical Findings in the Dermatology Clinic?
Choi JW; Kim BR; Seo E; Youn SW
Ann Dermatol; 2017 Feb; 29(1):48-54. PubMed ID: 28223746
[TBL] [Abstract][Full Text] [Related]
57. Treatment of nail psoriasis with TNF-α or IL12/23 inhibitors.
Jemec GB; Ibler KS
J Drugs Dermatol; 2012 Aug; 11(8):939-42. PubMed ID: 22859238
[TBL] [Abstract][Full Text] [Related]
58. Nail involvement features in palmoplantar pustulosis.
Kim M; Yang S; Kim BR; Youn SW
J Dermatol; 2021 Mar; 48(3):360-365. PubMed ID: 33305841
[TBL] [Abstract][Full Text] [Related]
59. Secukinumab demonstrates high and sustained efficacy in nail psoriasis: post hoc analysis from phase III trials in patients with psoriatic arthritis.
Reich K; Baraliakos X; Coates LC; Elewski B; Bao W; Kasparek T; Gaillez C; Pournara E; Aassi M; Perella C; Gottlieb AB
Br J Dermatol; 2022 Sep; 187(3):438-441. PubMed ID: 35257363
[TBL] [Abstract][Full Text] [Related]
60. [How to diagnose and treat psoriasis of the nails].
Baran R
Presse Med; 2014 Nov; 43(11):1251-9. PubMed ID: 25443636
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
